EFFECT OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS OF THE LOBEGLITAZONE

被引：0
|
作者：
Choi, H.
Jung, J.
Choi, Y.
Seo, J.
Ghim, J.
Kim, E.
Shin, J.
机构：
[1] Inje Univ, Coll Med, Dept Pharmacol, Busan, South Korea
[2] Inje Univ, Coll Med, Pharmacogen Res Ctr, Busan, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2016年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-103
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [1] Effect of Renal Impairment on the Pharmacokinetics of Grepafloxacin
    Constantin Efthymiopoulos
    Steven L. Bramer
    Allan Maroli
    John G. Gambertoglio
    [J]. Clinical Pharmacokinetics, 1997, 33 : 32 - 38
  • [2] EFFECT OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS OF CIBENZOLINE
    MASSARELLA, JW
    KHOO, KC
    AOGAICHI, K
    DIPERSIO, D
    SMITH, M
    KLUGER, J
    CHOW, MS
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (03) : 317 - 323
  • [3] Effect of renal impairment on the pharmacokinetics of exenatide
    Linnebjerg, Helle
    Kothare, Prajakti A.
    Park, Soomin
    Mace, Kenneth
    Reddy, Shobha
    Mitchell, Malcolm
    Lins, Robert
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 64 (03) : 317 - 327
  • [4] Effect of renal impairment on the pharmacokinetics of grepafloxacin
    Efthymiopoulos, C
    Bramer, SL
    Maroli, A
    Gambertoglio, JG
    [J]. CLINICAL PHARMACOKINETICS, 1997, 33 (Suppl 1) : 32 - 38
  • [5] EFFECT OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS OF CIBENZOLINE
    DIPERSIO, D
    CHOW, MSS
    KLUGER, J
    KHOO, KC
    MASSARELLA, JW
    ROTTENBERG, D
    AOGAICHI, K
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (02) : 190 - 190
  • [6] EFFECT OF RENAL IMPAIRMENT ON IPTACOPAN PHARMACOKINETICS
    Schmouder, Robert
    Lestini, Giulia
    Bartels, Christian
    Baltcheva, Irina
    Junge, Guido
    Kulmatycki, Kenneth
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I396 - I396
  • [7] EFFECT OF RENAL IMPAIRMENT ON RETIGABINE PHARMACOKINETICS
    Shin, Paul
    Loewen, G.
    Mansbach, H.
    Marbury, T.
    Riff, D. S.
    Schwartz, S.
    Taber, Louise A.
    Cannon, C.
    [J]. EPILEPSIA, 2008, 49 : 116 - 116
  • [8] Effect of Renal Impairment on the Pharmacokinetics of Memantine
    Moritoyo, Takashi
    Hasunuma, Tomoko
    Harada, Kazuhiro
    Tateishi, Tomonori
    Watanabe, Makoto
    Kotegawa, Tsutomu
    Nagai, Masahiro
    Kumagai, Yuji
    Fujitani, Tomomichi
    Okura, Takahumi
    Fukuoka, Tomikazu
    Miyoshi, Kenichi
    Matsuura, Bunzo
    Furukawa, Shinya
    Kobori, Tomoe
    Moritoyo, Hiroyoko
    Nishikawa, Noriko
    Tsujii, Tomoaki
    Iwaki, Hirotaka
    Nakamura, Masahiko
    Makino, Satoshi
    Ohnuma, Kei
    Yuji, Koichiro
    Hashimoto, Megumi
    Takasu, Masaru
    Hashizume, Yutaka
    You, Koji
    Matsumura, Tomoko
    Tanaka, Yuji
    Matsumoto, Nahoko
    Nakamura, Junichi
    Miura, Jun
    Akizawa, Tadao
    Kitazawa, Kozo
    Shibata, Takanori
    Kuroki, Aki
    Honda, Hirokazu
    Mukai, Masanori
    Ohashi, Kyoichi
    Morimoto, Takuya
    Imai, Hiromitsu
    Okudaira, Toshiaki
    Sato, Fuminori
    Imanaga, Junko
    Tanaka, Katsuhiro
    Nomoto, Masahiro
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 119 (04) : 324 - 329
  • [9] Effect of Ketoconazole on Lobeglitazone Pharmacokinetics in Korean Volunteers
    Oh, Eun Sil
    Kim, Choon Ok
    Kim, Ki Hyon
    Kim, Youn Nam
    Kim, Chin
    Lee, Jangik I.
    Park, Min Soo
    [J]. CLINICAL THERAPEUTICS, 2014, 36 (07) : 1064 - 1071
  • [10] Effect of Renal or Hepatic Impairment on the Pharmacokinetics of Mirabegron
    James Dickinson
    Michaelene Lewand
    Taiji Sawamoto
    Walter Krauwinkel
    Marloes Schaddelee
    James Keirns
    Virginie Kerbusch
    Selina Moy
    John Meijer
    Donna Kowalski
    Richard Morton
    Kenneth Lasseter
    Dennis Riff
    Viera Kupčová
    Marcel van Gelderen
    [J]. Clinical Drug Investigation, 2013, 33 : 11 - 23
12345